Headline
The latest stories from AHA Today.
The Senate Finance Committee Feb. 4 voted 14-13 to advance Robert F. Kennedy Jr.鈥檚 nomination for secretary of the Department of Health and Human Services.
The Senate Feb. 4 confirmed Doug Collins as the new Department of Veterans Affairs secretary by a 77-23 vote.
The Coalition to Strengthen America鈥檚 Healthcare has released its first year-end report, highlighting accomplishments from 2024. Among its efforts, Coalition advocates sent more than 173,000 letters to Congress and shared more than 3,700 personal health care stories. Eight videos were produced and鈥
A case study by the AHA's Community Health Improvement network explains how Providence Health and Services took a data-driven, measurement-based approach to give local hospitals in seven states autonomy to identify and address the health system鈥檚 community health priorities.
In this new 鈥淐aring for Our Kids鈥 episode, David Wagner, pediatric psychologist at Oregon Health and Science University, discusses the Novel Interventions in Children's Healthcare program and how this innovative approach is transforming care for vulnerable children.
The AHA Jan. 31 commended Sens. Bill Cassidy, R-La., Catherine Cortez Masto, D-Nev., John Cornyn, R-Texas., and Michael Bennet, D-Colo., on draft legislation that would increase the number of Medicare-funded physician residency positions.
The White House Feb. 1 announced it placed tariffs on imported goods from Canada, Mexico and China.
Case study: How Renown Health used its CHA to address needs following significant population growth聽
A case study by the AHA's Community Health Improvement network highlights how Renown Health in Reno, Nev., used its community health assessment to address local needs and changing demographics amid a significant population increase.
Linda Burnes Bolton, former president of AHA鈥檚 American Organization for Nursing Executives (now known as the American Organization for Nursing Leadership), and chief nursing officer at Cedars-Sinai Medical Center in Los Angeles, died this month at age 76. She was known for inspiring a generation鈥
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to severe acute pain in adults.